TCS New York City Marathon

SUNDAY, NOVEMBER 1, 2020

New York City, New York

Join us in celebrating the 50th Anniversary of the TCS New York City Marathon in 2020!

The TCS New York City Marathon course is a 26.2-mile block party through the world’s most diverse city. When you run with Parkinson's Champions you will be running through NYC’s five boroughs to achieve a personal goal. But for the 1 million Americans living with Parkinson's disease, it means so much more.

Parkinson's Champions Runners receive:

  • Guaranteed race entry
  • Parkinson's Champions running singlet for race day
  • Personalized online fundraising page
  • Invitation to race weekend events including pre-race pasta party for you and a guest
  • One-on-one fundraising support

Two Fundraising Options:

$3,500 – receive all the benefits above, and we will cover your entry fee
Or
$3,200 – receive benefits above but cover your own entry fee

Register as an individual or grab friends, family and colleagues to form a team to train and fundraise together!

To participate with Parkinson's Champions in the TCS New York City Marathon, fill out the application below. If you have questions, send an email to champions@parkinson.org. For more information, visit the TCS New York City Marathon.

X
 

Sign Up for Our E-Newsletter

Get the latest news about PD research, resources and community initiatives – straight to your inbox.

Please enter a valid email

Skip step



Invalid year format. Eg: 2020
Skip step
Skip step


*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news.

Skip step

Thanks for Signing Up

We are proud to have you as a part of our community. To ensure you receive the latest Parkinson’s news, research updates and more, please check your email for a message from us. If you do not see our email, it may be in your spam folder. Just mark as “not spam” and you should receive our emails as expected.

mail icon

Subscribe here to get the latest news on treatments, research and other updates.